Entry to the instructions for use
Groprinosin - complex preparation of antiviral action, which has excellent properties, activating the protective functions. The complex compounds inosine block the reproductive properties of the virus body, increase the active lymphocytes, macrophages, cells of cytokines. This drug lowers a bright severity of symptomatic manifestations of viral diseases direction that increases the body's resistance to various bacteria. Groprinosin often also designated as an additional preparation for combating herpes viruses epidermis, mucosa.1. pharmachologic effect
Drug group:
Antiviral drug.Therapeutic effects Groprinosina:
- Antiviral.
Features:
- The therapeutic effect of the drug develops after half an hour after its application and lasts for about 6 hours;
- The drug does not produce accumulation and completely eliminated from the body through two days.
2. Indications for use
The drug is used for:
- Treatment of various infectious diseases of viral origin.
3. Mode of application
The recommended dosage for children Groprinosina:
- SARS, influenza, parainfluenzaviral bronchitis, Infectious mononucleosis, Herpes zoster, cytomegalovirus or herpes infection: 50 mg per kg body weight per day, by dividing the resulting number by 3-4 Hour;
- Mumps, aphthous stomatitis: 70 mg per kg body weight per day, by dividing the resulting number by 3-4 Hour;
-
Measles: 100 mg per kg body weight per day, by dividing the resulting number by 3-4 Hour.
Recommended dosage for adults Groprinosina:
- SARS, flu, Parainfluenza, herpes zoster, herpes infection, hepatitis B, recurrent viral diseases of the genitourinary system: 2 tablets 3-4 times a day;
- Viral bronchitis, Genital herpes, human papillomavirus infection: 2 tablets 3 times a day;
-
thrush: 2 tablets 4 times a day;
- Subacute sclerosing panencephalitis: 50-100 mg per kg body weight per day, by dividing the number obtained by 6 receptions.
The recommended duration of application Groprinosina:
- SARS, influenza, parainfluenza: 5-7 days;
- Viral bronchitis: 2-4 weeks;
- Mumps: 7-10 days;
-
Measles: 7-15 days;
-
thrush: 6-7 weeks;
-
Infectious mononucleosis: 8 days;
- Cytomegalovirus infection: 1 month;
- Herpes infection, herpes zoster: 10-15 days;
- Genital herpes: 5-6 days;
- Subacute sclerosing panencephalitis: 8-10 days;
- Human papillomavirus infection: 14-28 days;
- Hepatitis B: 3-7 months;
- Recurrent viral diseases of the genitourinary system: 2-12 weeks.
Features of the application:
- According to the instructions, the prolonged use of the drug should be accompanied by monitoring activity liver, peripheral blood picture, uric acid levels in the urine and plasma, as well as activities kidney.
4. Side effects
-
Nervous system:
headaches, dizziness, sleep disturbances, fatigue, weakness, nervousness;
-
Digestive system:
nausea, vomiting, increased levels of alkaline phosphatase and / or enzymes, stomach pain, stool disturbances, loss of appetite;
-
Urinary system:
polyuria;
-
The immune system:
hives, Itching and rash, angioedema;
-
Musculoskeletal system:
arthralgia;
-
Results of laboratory studies:
increase in BUN levels in the plasma.
5. Contraindications
-
Urolithiasis disease, hyperuricemia,
- Hypersensitivity or idiosyncrasy Groprinosina or its components;
- Age less than 1 year;
- Pregnancy and lactation;
-
kidney failure.
Use with caution:
- Elderly age;
- Urolithiasis, renal dysfunction, gout in the history of the disease;
- The simultaneous use of allopurinol, loop or thiazide diuretics;
- Driving a car or potentially life-threatening activities.
6. Pregnancy and lactation
Pregnant women and nursing mothers taking the drug do not do it.7. Interaction with other drugs
Clinically significant Groprinosina negative interaction with other drugs has not been described.8. Overdose
Clinically significant symptoms of overdose Groprinosinom found.9. release Form
- Coated tablets, 500 mg - 20, 30 or 50 pieces.
10. Storage conditions
- Dry dark place without access for children;
- The normal level of humidity in the room.
Recommended storage temperature Groprinosina
- in the range of 15-25 degrees.Recommended shelf life
- not more than 2 years.11. Structure
1 tablet:
- inosine pranobex - 500 mg;
- Excipients: potato starch, polyvinylpyrrolidone K25, magnesium stearate.
12. Conditions of supply of pharmacies
The drug is released under the prescription of the attending physician.- Found a mistake? Select it and press Ctrl + Enter
